Related Experiment Video
Updated: Feb 2, 2026

Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
Genomics of Klebsiella pneumoniae ST16 producing NDM-1, CTX-M-15, and OXA-232
P Espinal1, E Nucleo2, M Caltagirone2
1Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; Servei de Microbiologia Hospital de la Santa Creu i Sant Pau, Institut d'Investigaciò Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.
Objectives:
Genomic characterization of the internationally spread sequence type (ST) 16 carbapenem-resistant Klebsiella pneumoniae.
Methods:
The complete genomes of three carbapenem producing ST16 K. pneumoniae from Italian patients were analysed by single-nucleotide polymorphism-based phylogeny, core genome multilocus sequence typing, resistance, plasmid, and virulence content and compared with ten genomes of ST16 strains isolated in other countries. Plasmids carrying blaNDM-1 or blaOXA-232 carbapenemase genes were assembled and sequences were analysed.
Results:
The internationally spread ST16 K. pneumoniae clone showed variability in terms of distribution of NDM-1 and OXA-232 type carbapenemases. In some ST16 strains, up to six plasmids can be simultaneously present in the same cell, including ColE-like plasmids carrying blaOXA-232 and IncF plasmids carrying blaNDM-1. The differences observed in plasmid, resistance, and virulence content and core genome suggested that there is not a unique, highly conserved ST16 clone, but instead different variants of this lineage circulate worldwide.
Conclusions:
The ST16 K. pneumoniae clone has spread worldwide and may become a high-risk clone.
Insights
The Sequence Type 16 (ST16) Klebsiella pneumoniae clone has spread globally, exhibiting variations in carbapenemase genes and plasmids. This adaptable lineage poses a significant public health risk.
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a global health threat.
- Sequence Type 16 (ST16) is an emerging lineage of CRKP with international spread.
Purpose of the Study:
- To genomically characterize the internationally spreading ST16 CRKP clone.
- To investigate the genetic basis of carbapenem resistance and plasmid content in ST16 strains.
Main Methods:
- Whole-genome sequencing of Italian ST16 CRKP isolates.
- Comparative genomic analysis with international ST16 strains.
- Phylogenetic analysis, core genome MLST, and plasmid content analysis.
Main Results:
- ST16 CRKP exhibits variability in carbapenemase genes (blaNDM-1, blaOXA-232).
- Strains harbor multiple plasmids, including those carrying carbapenemase genes.
- Genomic and plasmid content differences indicate diverse circulating variants, not a single conserved clone.
Conclusions:
- The ST16 K. pneumoniae clone is globally disseminated.
- Its genetic diversity and resistance mechanisms suggest it may become a high-risk clone.
Related Concept Videos
Genomics
Other Nuclides: 31P, 19F, 15N NMR
While fluorine-19 and phosphorous-31 have high natural abundances (100%) and positive gyromagnetic ratios, nitrogen-15 has a low natural abundance and a negative gyromagnetic ratio. However, nitrogen-15 is still preferred over nitrogen-14 (which has a...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

